Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Xiaoling Xu, Binqing Fu et al.|Frontiers of Medicine|2021Cited by 80
The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes MellitusMao Zheng, Shandong Ye, Yan Ma et al.|Journal of Diabetes Research|2021Cited by 53
T Cells Expanded from PD-1+ Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating LymphocytesTiepeng Li, Quanli Gao, Lingdi Zhao et al.|Cancer Research|2021Cited by 40
Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter TrialDongsheng Wang, Xiaoling Xu, Binqing Fu et al.|SSRN Electronic Journal|2020Cited by 18
A risk signature with inflammatory and immune cells infiltration predicts survival and efficiency of chemotherapy in gastric cancerSen Li, Yuzhou Zhao, Yan Ma et al.|International Immunopharmacology|2021Cited by 6